[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100489187":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":19,"centralContacts":24,"locations":31,"responsibleParty":47,"collaborators":49,"id":53,"slug":19,"hasResults":54,"nctId":55,"briefTitle":56,"officialTitle":57,"acronym":58,"eligibilityCriteria":59,"healthyVolunteers":54,"sex":60,"minAge":61,"maxAge":19,"enrollmentInfo":62,"targetDuration":19,"studyType":65,"phases":66,"briefSummary":68,"conditions":69,"keywords":19,"overallStatus":34,"whyStopped":19,"lastUpdateSubmitDate":71,"lastUpdatePostDateStruct":72,"startDateStruct":75,"completionDateStruct":77,"leadSponsor":79,"locationsCount":80},{"fullName":5,"class":6},"GCS Ramsay Santé pour l'Enseignement et la Recherche","OTHER",[8],{"label":9,"type":6,"description":10,"interventionNames":11},"Chemotherapy","Adjuvant chemotherapy treatment",[12,13],"Other: Socio-aesthetic care","Other: Supportive care",[15,20],{"type":6,"name":16,"description":17,"armGroupLabels":18,"otherNames":19},"Socio-aesthetic care","Group A (Socio-aesthetic care): 3 sessions carried out by a socio-esthetician, during the first administration of chemotherapy.",[9],null,{"type":6,"name":21,"description":22,"armGroupLabels":23,"otherNames":19},"Supportive care","Group B (control) will not benefit of socio-aesthetic care during chemotherapy but will benefit all existing support care in the center and accessible to patients: psychology consultation, sophrology, art therapy, physiotherapy, hypnosis. The patient will receive support care (maximum 2) during the intercure.",[9],[25],{"name":26,"role":27,"phone":28,"phoneExt":29,"email":30},"Louis DOUBLET, MD","CONTACT","4 75 75 87 93","+33","l.doublet@ramsaygds.fr",[32],{"facility":33,"status":34,"city":35,"state":19,"zip":36,"country":37,"countryCode":38,"cosmosGeoPoint":39,"geoPoint":44,"contacts":45},"Hôpital Privé Drôme Ardèche","RECRUITING","Valence","26000","France","FR",{"type":40,"coordinates":41},"Point",[42,43],4.90956,44.9256,{"lat":43,"lon":42},[46],{"name":26,"role":27,"phone":28,"phoneExt":29,"email":30},{"type":48,"investigatorFullName":19,"investigatorTitle":19,"investigatorAffiliation":19,"oldNameTitle":19,"oldOrganization":19},"SPONSOR",[50],{"name":51,"class":52},"Euraxi Pharma","INDUSTRY","100489187",false,"NCT05649852","Anxiolytic Effects of Socio-aesthetics in Cancer Patients Undergoing Chemotherapy","Anxiolytic Effects of Socio-aesthetics in Cancer Patients Undergoing Chemotherapy (PASITHEA)","PASITHEA","Inclusion Criteria:\n\n* Patient with cancer treated with adjuvant chemotherapy with an interval of 14 or 21 days for the first 3 cycles;\n* Chemotherapy naïve patient;\n* Patient speaking and understanding French and able to complete the questionnaires;\n* Patient having been informed and having signed an informed consent form to participate in the study.\n\nExclusion Criteria:\n\n* Patient who has already benefited from socio-aesthetic care;\n* Protected patient (under legal protection, or deprived of liberty by judicial or administrative decision);\n* Patient unable to understand the information related to the study (linguistic, psychological, cognitive reasons, etc.);\n* Pregnant or likely to be pregnant (of childbearing age, without effective contraception) or breastfeeding;\n* Patient participating in another clinical trial, or in a period of exclusion from another clinical trial;\n* Patient not benefiting from a social security scheme.","ALL","18 Years",{"count":63,"type":64},192,"ESTIMATED","INTERVENTIONAL",[67],"NA","The purpose of the study is to assess the average of the \"State Anxiety\" score of the State Trait Inventory Anxiety at the end of the third cycle of chemotherapy compared to the pre-treatment score (inclusion)",[70],"Chemotherapy Effect","2026-01-13",{"date":73,"type":74},"2026-01-15","ACTUAL",{"date":76,"type":74},"2023-03-23",{"date":78,"type":64},"2027-06-30",{"name":5,"class":6},1]